As the demand for COVID vaccines decreases worldwide, Moderna is planning to release a RSV vaccine, pending U.S. approval.
Moderna posted a narrower-than-expected loss for the first quarter as the company's cost-cutting efforts took hold and sales ...
At its annual Vaccines Day and Business Update on Wednesday, Moderna (MRNA) sought to show analysts and investors just how much its pipeline has advanced, four years after making history by ...
AstraZeneca Plc pulled its Covid-19 vaccine from the market due to lack of demand for a shot that initially raised hopes it would play a key role in protecting the world against the virus.
The continued evolution of SARS-CoV-2 into new variants, each as or more infectious than the last, underscores the ongoing need to update our vaccine defenses against the virus. While updated ...
A guide to the coronavirus vaccination rollout and what you need to know about the authorized vaccines Some 63.8% of Americans have received both doses of the two-shot Pfizer-BioNTech and Moderna ...
Pfizer, Inc. on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, driving shares down 9% to a 10-year low. Moderna says its updated coronavirus ...
A Victorian coroner is investigating whether a young woman's death from heart inflammation after receiving her third Covid-19 jab was caused by the Moderna vaccine. Moderna's lawyers appeared ...
When Brad Miller became the chief information officer at drugmaker Moderna in early 2023, he already had a strong background in finance and technology, but no expertise in health care. “Learning ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. A top-five shareholder in struggling Covid-19 vaccine maker Novavax is calling for an “urgent shake-up ...
WATCH: Nobel in medicine goes to scientists whose work on mRNA led to COVID vaccine Hungarian-American Katalin Karikó and American Drew Weissman were cited for contributing vaccine development ...